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Abstract
Background: Early identification of stroke is crucial to maximize early management benefits in emergency
departments. This study aimed to develop and validate a new stroke recognition instrument for differentiating
acute stroke from stroke mimics in an emergency setting.
Methods: A prospective observational cohort study among suspected stroke patients presenting to Emergency
Department in the Second Affiliated Hospital of Guangzhou Medical University was conducted from May 2012 to
March 2013. The symptoms and signs of suspected stroke patients were collected. Logistic regression analysis was
used to identify the factors associated with acute stroke. The symptoms and signs closely associated with acute
stroke were selected to develop the new stroke scale, Guangzhou Stroke Scale (GZSS). The diagnostic value of GZSS
was then compared with ROSIER, FAST and LAPSS. The primary outcome was confirmed stroke by CT within 24 h.
Results: Four hundred and sixteen suspected stroke patients (247 ischemia, 107 hemorrhage, 4 transient ischemic
attack, 58 non-stroke) were assessed. A new stroke scale, GZSS (total score from −1 to 8.5), was developed and
consisted of nine parameters: vertigo (−1), GCS ≤ 8 (+2), facial paralysis (+1), asymmetric arm weakness (+1),
asymmetric leg weakness (+1), speech disturbance (+0.5), visual field defect (+1), systolic blood pressure ≥145 mmHg
(+1) and diastolic blood pressure ≥95 mmHg (+1). Among the four scales, the discriminatory value (C-statistic) of GZSS
was the best (AUC: 0.871 (p < 0.001) when compared to ROSIER (0.772), LAPSS (0.722) and FAST (0.699). At an optimal
cut-off score of >1.5 on a scale from −1 to 8.5, the sensitivity and specificity of GZSS were 83.2 and 74.1 %, whilst the
sensitivities and specificities of ROSIER were 77.7 and 70.7 %, FAST were 76.0 and 63.8 %, LAPSS were 56.4 and 87.9 %.
Conclusion: GZSS had better sensitivity than existing stroke scales in Chinese patients with suspected stroke. Further
studies should be conducted to confirm its effectiveness in the initial differentiation of acute stroke from stroke mimics.
Keywords: Diagnosis, Stroke, Stroke mimics, ROSIER scale, FAST scale, LAPSS scale, Emergency department, China
Abbreviations: AUC, area under the ROC curve; CT, computed tomography; DWI, diffusion weighted imaging; FAST,
the face arm speech test; GCS, Glasgow Coma Scale; IQR, inter quartile range; LAPSS, the Los Angeles Prehospital Stroke
Screen; MRI, magnetic resonance imaging; NIHSS, National Institute of Health stroke scale; OR, odds ratio; ROC, receiver
operating characteristic; ROSIER, the Recognition of Stroke in the Emergency Room scale; TIA, transient ischemic attack
Background
Stroke is one of the most common acute and severe dis-
eases presenting to an emergency department (ED) [1].
The early assessment and management of stroke patients
should reduce morbidity and mortality [1]. The use of a
stroke screening tool to identify the symptoms and signs of
suspected stroke and TIA increases diagnostic accuracy of
medical staff in pre-hospital and ED [1]. The widely rec-
ommended stroke scales in the western world include the
Recognition of Stroke in the Emergency Room scale
(ROSIER), the Face Arm Speech Test (FAST) and the Los
Angeles Prehospital Stroke Screen (LAPSS). ROSIER is a
seven-item ranging score from −2 to +5 that includes the
clinical history (loss of consciousness, convulsive fit) and
neurological signs (face, arm, or leg weakness, speech dis-
turbance, visual field defect). FAST contains three key ele-
ments including facial weakness, arm weakness, and
speech disturbance. LAPSS consists of four history items, a
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blood glucose measure, and three examination items de-
signed to detect unilateral motor weakness [2–5]. However,
our previous study demonstrated these three stroke scales
were not effective for differentiating stroke from stroke
mimics in Chinese settings [6, 7]. The reasons may be re-
lated to the difference in factors affecting the incidence of
stroke subtypes and stroke mimic in different ethnic popu-
lations [8]. Therefore, it is necessary to develop a stroke
scale suitable to a Chinese emergency setting.
The aims of our study were firstly to identify factors
that predict stroke, secondly to develop a new stroke
scale in our emergency setting, and thirdly to compare
the diagnostic value of the new stroke scale with
ROSIER, FAST and LAPSS.
Methods
Study design
A prospective observational study of patients with sus-
pected stroke was conducted from May 2012 to March
2013. Ethical approval was obtained from the Clinical
Research Ethics Committee of the 2nd Affiliated Hospital
of Guangzhou Medical University. Written consents were
also obtained from all patients or the closest available rela-
tives. Patients were informed that they might withdraw
from the study at any time.
Study setting
This study was conducted in the emergency department
of the second Affiliated Hospital of Guangzhou Medical
University (AHGZMU), which serves a population of ap-
proximately 1.56 million people in the Hai Zhu district,
Guangzhou. It is an academic hospital with 1500 beds
affiliated with the Guangzhou Medical University. The
ED receives more than 150,000 new patients per annum
and serves a local population of approximately 1,550,000
people.
Inclusion and exclusion criteria
Suspected stroke patients ≥18 years old presenting to the
ED with symptoms or signs within 7 days were recruited.
Patients were excluded if they were <18 years old, had
traumatic brain injury, subarachnoid hemorrhage, or un-
known diagnoses.
Measurements and data collection
Demographic data, clinical manifestations, risk factors,
medical history information and the assessment of
ROSIER, FAST and LAPSS were collected [2, 3]. The
final diagnosis was made by a specialist stroke physician
after assessment and review of clinical symptoms and
brain imaging findings (CT or MR). All the patients
were divided into stroke or non-stroke groups based on
the final diagnosis. Glasgow Coma Scale (GCS) was used
to assess the severity of coma (the motor score was ap-
plied to the non-affected limb) [9]. All the patients’ scores
in this study were assessed by an emergency doctor who
has obtained the certification of National Institute of
Health Stroke Scale.
Fig. 1 Flowchart of stroke patient recruitment
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Definitions
Stroke was defined as a focal or global neurological
deficit with symptoms lasting for 24 h or resulting in
death before 24 h, which was thought to be due to a
vascular cause after investigation [3]. TIA was defined
as clinical syndromes characterized by an acute loss
of focal cerebral or monocular function with symp-
toms lasting less than 24 h and thought to be caused
by in adequate blood supply as a result of thrombosis
or embolism [3]. Vertigo is defined as the illusion of
movement in space [10].
Statistical analyses
Categorical variables were compared using Chi-square
analysis, whilst continuous variables were compared
using independent t-tests. Univariate analysis was ini-
tially used on all variables, and results were presented as
ORs with 95 % CIs. Variables that were identified as
significant from the univariate analysis (p < 0.05) were en-
tered into logistic regression models to identify independ-
ent factors for differentiation of stroke from stroke
mimics. The backward stepwise regression analyses were
used to construct the models. Significant predictive
Table 1 Baseline demographic characteristics of stroke and non-stroke patients (n = 416)
Variables Stroke n = 358 Non-stroke n = 58 P
Age 69.2 ± 13.8 70.6 ± 11.4 0.397
Male, n (%) 210 (58.7) 37 (63.8) 0.460
SBP, mmHg 168.8 ± 31.9 147.8 ± 27.6 <0.001*
DBP, mmHg 91.8 ± 20.7 80.8 ± 14.3 <0.001*
bpm 80.9 ± 18.1 80.0 ± 13.3 0.742
Medical history, n (%)
Smoker 146 (40.8) 20 (34.5) 0.339
Hypertension 202 (56.4) 34 (58.6) 0.992
Diabetes 58 (16.2) 14 (24.1) 0.157
Hyperlipidemia 40 (11.2) 9 (15.5) 0.407
Ischemic heart disease 36 (10.1) 8 (13.8) 0.434
Atrial fibrillation 28 (7.8) 1 (1.7) 0.148
Symptoms & signs, n (%)
Asymmetric facial weakness 181 (50.6) 8 (13.8) <0.001*
Asymmetric arm weakness 217 (60.6) 7 (12.1) <0.001*
Asymmetric leg weakness 228 (63.7) 9 (15.5) <0.001*
Speech disturbance 195 (54.5) 17 (29.3) <0.001*
Visual field defect 68 (19.0) 1 (1.7) 0.001*
gaze palsy 115 (32.1) 5 (8.6) <0.001*
Sensory deficits 78 (21.8) 8 (13.8) 0.163
Loss of consciousness or syncope 119 (33.2) 10 (17.2) 0.015*
Seizure activity 21 (5.9) 6 (10.3) 0.319
Pathologic reflex 102 (28.5) 8 (13.8) 0.019*
Meningeal irritation 22 (6.1) 0 (0) 0.102
Vertigo 26 (7.3) 19 (32.8) <0.001*
Headache 25 (7.0) 3 (5.2) 0.816
Nausea 59 (16.5) 26 (44.8) <0.001*
Vomiting 51 (14.2) 23 (39.7) <0.001*
Score
GCS > 8, n (%) 297 (83) 56 (96.6) 0.007*
GCS≤ 8, n (%) 61 (17) 2 (3.4) 0.007*
GCS, median (IQR) 15 (12–15) 15 (15–15) <0.001*
*Statistically significant difference was observed between two groups
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variables generated in the first model were selected for the
final model. The receiver operating characteristics (ROC)
curve analysis was utilized to determine the optimal cut-
off value of GZSS for discriminating between patients
with stroke and stroke mimic. Diagnostic performances of
the new stroke scale, ROSIER, FAST and LAPSS were also
compared using ROC analysis. The sensitivities, specific-
ities, positive and negative predictive values (PPV and
NPV), positive and negative likelihood ratios (LR+ and
LR-), and diagnostic accuracy were calculated. Statistical
significance was set at p < 0.05. All analyses were per-
formed using SPSS v17.0 (SPSS Inc, IL, USA) and Medcalc
v9.5 (MedCalc Software, Mariakerke, Belgium).
Results
Patient characteristics
Four hundred and sixteen patients were assessed between
May 2012 and March 2013. There were 358 (86.1 %)
stroke cases, including 247 (69.0 %) ischemic stroke, 107
(29.9 %) intracerebral hemorrhage, 4 (1.1 %) TIA, and 58
(13.9 %) non-stroke cases (Fig. 1). Compared with non-
stroke group, patients with stroke had higher systolic blood
pressure (SBP), diastolic blood pressure (DBP) and incidence
of several symptoms and signs including asymmetric facial
weakness, asymmetric arm weakness, asymmetric leg weak-
ness, speech disturbance, visual field defect, gaze palsy, loss
of consciousness or syncope and pathologic reflex (Table 1).
However, non-stroke patients had higher incidence of ver-
tigo, nausea and vomiting. The most common stroke
mimics were cervical spondylosis, seizure, peripheral vertigo,
which together composed 68.9 % of non-stroke cases
(Table 2). Among the 61 cases of stroke patients with GCS
≤8, there were 47 patients with intracerebral hemorrhage
(77 %) and 14 patients with ischemia stroke (23 %), includ-
ing 8 cases with total anterior circulation stroke and middle
cerebral artery occlusion, 3 cases with partial anterior circu-
lation stroke and stroke past history, 3 cases with posterior
circulation stroke located in brain stem (Table 3).
Development of the new stroke scale
Logistic regression analysis of clinical symptoms and
signs for stroke and non-stroke patients are shown in
Table 4. GCS ≤8 was recognized as the highest preva-
lence, following by visual field defect, asymmetric arm
weakness, asymmetric leg weakness, SBP ≥145 mmHg,
DBP ≥95 mmHg, speech disturbance and vertigo. As
shown in Table 5, the items of the new stroke scale with
total score from −1 to 8.5 included vertigo (−1), GCS ≤ 8
(+2), Asymmetric facial weakness (+1), asymmetric arm
weakness (+1), asymmetric leg weakness (+1), speech dis-
turbance (+0.5), visual field defect (+1), SBP ≥145 mmHg
(+1), DBP ≥95 mmHg (+1). We developed the new scale
based on P value of Multiple Logistic regression and odds
ratio (Tables 4 and 5).
Diagnostic performances of ROSIER, FAST, LAPSS and
GZSS
The nine-item scoring system for GZSS was constructed.
Comparison of GZSS to ROSIER, FAST and LAPSS was
undertaken using ROC analysis (Fig. 2). The area under
curve (AUC) of GZSS was 0.871 (95 % CI 83.5–90.2),
whilst the AUC of ROSIER was 0.772 (95% CI 72.8–
81.1), LAPSS was 0.722 (95 % CI 67.6–74.6) and FAST
was 0.699 (95 % CI 65.2–74.3). By pairwise comparison
of the AUC of the four scales (adjusted α = 0.008), the
comparison was statistically significant (p < 0.001).
Among the four scales, the diagnostic value of GZSS
was the best (Fig. 2).
The optimal cut-off score of GZSS was determined to
be a total score of 1.5. At this cut-off score, the corre-
sponding sensitivity and specificity were 83.2 % (95 % CI
79.0–87.0) and 74.1 % (95 % CI 61.0–84.7). The sensitiv-
ity and specificity of ROSIER scale were 77.7 % (95 % CI
73.0–81.9) and 70.7 % (95 % CI 57.3–81.9) when the
Table 2 Diagnoses of stroke and non-stroke patients (n = 416)
Diagnoses N (%)
Stroke classification 358 (100.0)
Total anterior circulation stroke 41 (11.5)
Partial anterior circulation stroke 97 (27.1)
Lacunar stroke 88 (24.6)
Posterior circulation stroke 21 (5.7)
Intracerebral Hemorrhage 107 (29.9)
Transient Ischemic attack 4 (1.1)
Non-stroke 58 (100.0)
cervical spondylosis 28 (48.3)
Seizure 6 (10.3)
Peripheral vertigo 6 (10.3)
Parkinson’s disease 2 (3.5)
Vasovagal syncope 2 (3.5)
Othera 14 (24.1)
aOther diagnoses: hyponatremia and hypokalemia (n = 1), hypoglycemic coma
(n = 1), alcoholic cirrhosis (n = 1), overdose of clozapine (n = 1), chronic
obstructive pulmonary disease (n = 1), cerebral arteriosclerosis (n = 1),
Hashimoto’s encephalopathy (n = 1), vascular headache (n = 1), medulla
oblongata and cervical vertebrae (C1-C2) focus (n = 1), scrub typhus (n = 1),
central nervous system infection (n = 1), periodic paralysis (n = 1), facial neuritis
(n = 1), left middle cerebral artery (M1) following stenting (n = 1)
Table 3 The subtype of stroke patients with GCS ≤ 8
Diagnoses N (%)
Intracerebral Hemorrhage 47 (77.0)
Ischemia stroke 14 (23.0)
Total anterior circulation stroke 8
Partial anterior circulation stroke 3
Posterior circulation stroke 3
Total 61 (100.0)
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optimal cut-off score was 0. The sensitivity and specifi-
city of FAST scale were 76.0 % (95 % CI 71.2–80.3) and
63.8 % (95 % CI 50.1–76.0) when the optimal cut-off
score was 0. The sensitivity and specificity of LAPSS
scale were 56.4 % (95 % CI 51.1–61.6) and 87.9 % (95 %
CI 76.7–95.0) when the optimal cut-off score was 0. The
sensitivity of GZSS was the best and was significantly
different from the sensitivities of ROSIER scale (p =
Table 4 Factors associated with stroke using logistic regression analysis
Variables Univariate regression Multivariate regression
N (%) OR (95 % CI) P OR (95 % CI) P
Female 169 (40.6) 1
Male 247 (59.4) 0.81 (0.45–1.43) 0.461
Age 0.99 (0.97–1.01) 0.457
GCS > 8 353 (84.9) 1
GCS≤ 8 63 (15.1) 5.75 (1.37–24.20) 0.017* 5.70 (1.26–25.80) 0.024*
Seizure activity
NO 389 (93.5) 1
YES 27 (6.5) 0.54 (0.21–0.54) 0.205
Vertigo
NO 371 (89.1) 1
YES 45 (10.8) 0.16 (0.08–0.32) <0.001* 0.34 (0.15–0.74) 0.007*
Asymmetric facial weakness
NO 227 (54.6) 1
YES 189 (45.4) 6.39 (2.95–13.87) <0.001* 2.44 (0.97–6.11) 0.057
Asymmetric arm weakness
NO 192 (46.2) 1
YES 224 (53.8) 11.21 (4.95–25.41) <0.001* 3.39 (1.04–11.08) 0.043*
Asymmetric leg weakness
NO 179 (43.0) 1
YES 237 (57.0) 9.55 (4.54–20.07) <0.001* 2.77 (0.88–8.70) 0.081
Speech disturbance
NO 204 (49.0) 1
YES 212 (51.0) 2.89 (1.58–5.27) 0.001* 1.29 (0.58–2.84) 0.524
Visual field defect
NO 347 (83.4) 1
YES 69 (16.6) 13.37 (1.82–98.23) 0.011* 3.93 (0.48–32.30) 0.202
Gaze palsy
NO 296 (71.2) 1
YES 120 (28.8) 5.02 (1.95–12.89) 0.001* 0.75 (0.19–3.08) 0.693
Pathologic reflex
NO 306 (73.6) 1
YES 110 (26.4) 2.49 (1.14–5.44) 0.022* 0.73 (0.28–1.91) 0.516
SBP≥ 145 mmHg
NO 111 (26.7) 1
YES 305 (73.3) 3.99 (2.25–7.07) <0.001* 2.55 (1.25–5.24) 0.011*
DBP≥ 95 mmHg
NO 270 (64.9) 1
YES 146 (35.1) 4.62 (2.04–10.48) <0.001* 2.29 (0.87–6.03) 0.093
*Statistically significant (p <0.05)
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0.031), FAST scale (p = 0.004) and LAPSS scale (p <
0.001) (Table 6).
Discussion
This was the first study to develop a new stroke scale in
China. In recent years, the incidence of stroke is still ris-
ing year by year around the world and its high morbidity
can cause serious social and family burden [11–14].
Early recognition and timely treatment of patients with
acute stroke by emergency physicians are critical and
improve the prognosis of stroke patients [15–22]. Stroke
screening scales were recommended by guidelines in
pre-hospital and emergency room for rapid triage of sus-
pected patients [1, 3, 23–25].
In this study, we found that there were significant dif-
ferences in the distribution of stroke subtypes between
the patients in our study and the Western patients in
the studies using other scales. There was a higher pro-
portion of intracerebral haemorrhage in our study com-
pared with the other Western studies [26–29]. Also,
there were less ischaemic stroke (69 versus 76 %) and
TIA (1.1 versus 10 %), but more haemorrhagic stroke
(29.9 versus 14 %) in our study than in the ROSIER
study [2]. These differences in subtype patterns are pos-
tulated to be due to differences in genetic, clinical, envir-
onmental and lifestyle factors [8, 30, 31]. There were
also differences in the proportion of stroke mimics be-
tween this study and the other Western studies, Seizures
(10.3 %) and syncope (17.2 %) in Guangzhou were less
common than in the UK (47 %) [2]. Another UK study
found that primary headache disorders and seizures
comprised up to 27 % of stroke mimics [32], whilst in
Greece [33] the principal stroke mimics were aphasic
disturbances (27.3 %) and dizziness or fainting (27.3 %).
We analyzed different clinical features of stroke in our
ED and thus developed a new stroke recognition instru-
ment (score range: −1 to 8.5), which consisted of nine
items including vertigo (−1), GCS ≤ 8 (+2), facial paraly-
sis (+1), asymmetric upper limb paralysis (+1), asymmet-
ric lower limb paralysis (+1), speech disorders (+0.5),
visual field defect (+1), SBP ≥145 mmHg (+1), DBP
≥95 mmHg (+1). The new stroke scale showed good dis-
criminative value in our ED.
In GZSS, five recognition items were the same as in
ROSIER scale, FAST score and LAPSS. These items with
different odds ratios were included in the new stroke
scale, such as asymmetric facial weakness (OR: 6.39),
asymmetric arm weakness (OR: 11.21), asymmetric leg
weakness (OR: 9.55), speech disturbance (OR: 2.89), vis-
ual field defect (OR: 13.37). We assigned the corre-
sponding score to each item of the new scale based on
the logistic regression coefficients.
There were some new items added in GZSS based on
the analysis. In our previous study, we found that the
level of consciousness of patients may affect the diagnos-
tic value of the stroke screening scales [2, 6, 7]. There-
fore, we assessed the diagnostic value of GCS in patients
with suspected stroke. We found that GCS equal or less
than 8 points (OR: 5.75) was associated with the diagno-
sis of stroke. Stroke patients often have disturbance of
consciousness and are unable to cooperate in medical
Table 5 Clinical signs and symptoms for development of the
new stroke scale
Variables Score β OR (95 % CI) P value
Vertigo −1 −1.09 0.34 (0.15–0.74) 0.007*
GCS≤ 8 2 1.74 5.70 (1.26–25.80) 0.024*
Asymmetric facial weakness 1 0.89 2.44 (0.97–6.11) 0.057
Asymmetric arm weakness 1 1.22 3.39 (1.04–11.08) 0.043*
Asymmetric leg weakness 1 1.02 2.77 (0.88–8.70) 0.081
Speech disturbance 0.5 0.26 1.29 (0.58–2.84) 0.524
Visual field defect 1 1.37 3.93 (0.48–32.30) 0.202
SBP≥ 145 mmHg 1 0.94 2.55 (1.25–5.24) 0.011*
DBP≥ 95 mmHg 1 0.83 2.29 (0.87–6.03) 0.093
*P < 0.05
Stroke is likely if total scores are >1.5
Fig. 2 Receiver operating characteristic ROC curves of GZSS, ROSIER,
FAST and LAPSS in differentiation of stroke and non-stroke patients
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Table 6 Diagnostic performance of ROSIER, FAST, LAPSS and GZSS
Scale Optimal cut-off Sensitivity (95 % CI) P Specificity (95 % CI) P PLR (95 % CI) NLR (95 % CI) PPV (95 % CI) NPV (95 % CI) Diagnostic accuracy (%)
ROSIER 0 77.7 (73.0–81.9) 0.031 70.7 (57.3–81.9) 0.754 2.65 (1.8–4.0) 0.32 (0.2–0.4) 94.2 (90.9–96.6) 33.9 (25.5–43.1) 76.68
FAST 0 76.0 (71.2–80.3) 0.004 63.8 (50.1–76.0) 0.210 2.1 (1.5–3.0) 0.38 (0.3–0.5) 92.8 (89.2–95.5) 30.1 (22.1–39.0) 74.28
LAPSS 0 56.4 (51.1–61.6) <0.001 87.9 (76.7–95.0) 0.008 4.68 (2.3–9.4) 0.50 (0.4–0.6) 96.7 (93.2–98.6) 24.6 (18.9–31.1) 60.82
GZSS 1.5 83.2 (79.0–87.0) Reference 74.1 (61.0–84.7) Reference 3.22 (2.1–5.0) 0.23 (0.2–0.3) 95.2 (92.2–97.3) 41.7 (32.1–51.9) 81.97
ROSIER Recognition of Stroke in the Emergency Room scale, FAST Face Arm Speech Test, LAPSS Los Angeles Pre-Hospital Stroke Screen, GZSS Guangzhou Stroke Scale, PLR positive likelihood ratio, NLR negative likelihood ratio,













examinations. It would be difficult for coma patients to
carry out some of the physical examinations, such as
paralysis and speech disorders. In this case, most of the
stroke screening scales developed in western countries,
such as FAST and LAPSS, cannot be applied to stroke
patients with loss of consciousness. Also, if stroke pa-
tients present with loss of consciousness and do not
have paralysis and speech disorders, the total score of
ROSIER scale is equal to or less than 0 and thus means
stroke is not likely to occur. This would easily lead to
false negative. Therefore, we included GCS in GZSS to
compensate the deficiency of the other stroke scales.
Vertigo was another new item in GZSS. Our study
suggested vertigo occurred more often in Chinese non-
stroke population than Western population. In the west-
ern population, the proportion of stroke and non-stroke
patients with vertigo were similar (6 and 5 %, respect-
ively) [2]. However, 58.6 % of patients had cervical spon-
dylosis and peripheral vertigo in this study. By logistic
regression analysis, the regression coefficient βof vertigo
was negative, which suggested that vertigo was a differ-
ential symptom between stroke and non-stroke patients.
In addition, our new scale included SBP and DBP. We
used ROC analysis to determine the optimal cut-off
values of SBP (≥145 mmHg) and DBP (≥95 mmHg). By
logistic regression analysis, we found that the OR of SBP
and DBP were2.55 and 2.29, respectively. When acute
stroke occurs, SBP and DBP are higher than usual. Blood
pressure of more than 80 % of patients increased within
24 to 48 h after the onset of cerebral ischemic, and de-
clined gradually in a few days or several weeks. One of the
reasons might be due to the regulation disorder of cere-
bral blood flow in ischemic penumbra [34, 35]. Patients
with hemorrhagic stroke experienced increased intracra-
nial pressure, and thus the blood pressure would increase
to maintain the normal cerebral blood flow. In this study,
the blood pressure was higher in patients with stroke than
non-stroke (p < 0.01). Also, 392 patients (94.2 %) including
337 stroke patients (81.0 %) and 55 non-stroke patients
(13.2 %) presented to ED within 24 h after symptom onset.
Only 5.8 % of patients presented over 24 h after symptom
onset. This indicated that the vast majority of patients
with suspected stroke in our study were in acute period of
cerebral apoplexy. Therefore, blood pressure also played a
significant role in the diagnosis of patients with suspected
stroke in the emergency department.
A comparison of the new stroke scale with the other
three scales (ROSIER scale, FAST scale and LAPSS scale)
was conducted in our ED. We found that the new scale
had better sensitivity than the other scales. The AUC of
GZSS was the largest (AUC = 0.871). At the optimal cut-
off score of 1.5, GZSS gave high sensitivity and compar-
able specificity. It may be more effective to use GZSS to
screen Chinese patients with suspected stroke in ED.
Limitations
There were several limitations in this study. First, this
study was a single-center study. Our results may not be
generalizable to other parts of China, let alone elsewhere
in the world. Multicenter studies with larger sample
sizes are needed to explore the effectiveness of this new
stroke scale. Second, using GCS in GZSS may not be ap-
propriate in all circumstances. A patient who has had a
stroke may be aphasic and hemiplegic. They may be fully
conscious but only scored E4V1M6 giving them a GCS
of 11/15, which is clearly misleading. It may be necessary
to break down the GCS into the component parts (i.e.
E4V1M6 instead of GCS 9) to get much more informa-
tion. Third, it would have been stronger to have separate
derivation and validation datasets rather than a single
dataset. Therefore, further studies with larger sample
sizes are required to validate the effectiveness of GZSS
and improve its weakness.
Conclusion
GZSS had better sensitivity than the existing stroke
scales in Chinese patients with suspected stroke. Further
studies are required to validate its usefulness in the ini-
tial differentiation of acute stroke from stroke mimics.
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